Somatostatin type 2 receptor antibody enhances mechanical hyperalgesia in the dorsal root ganglion neurons after sciatic nerve-pinch injury: Evidence of molecular and behavioral studies.
Our previous study has indicated that somatostatin potently inhibits neuropathic pain through activation of its type 2 receptor (SSTR2) in mouse dorsal root ganglion and spinal cord. However, the underlying mechanism of this activation has not been elucidated clearly. To perform the painful behavior and pharmacological studies on the basis of sciatic nerve-pinch mice model and explore the underlying mechansim which SSTR2 involved. On the basis of a sciatic nerve-pinch injury model, we aimed at comparing the painful behavior and dorsal root ganglion neurons neurochemical changes after the SSTR2 antibody (anti-SSTR2;5μl,1μg/ml) administration in mouse. After pinch nerve injury, we found that the mechanical hyperalgesia and severely painful behavior (autotomy) were detected after the application of SSTR2 antibody (anti-SSTR2;5μl,1μg/ml) on the pinch-injured nerve.The up-regulated phosphorylated ERK (p-ERK) expression and the apoptotic marker (i.e., Bax) was significantly decreased in DRGs after anti-SSTR2 treatment. The current data suggested that inhibitory changes in proteins from the apoptotic pathway in anti-SSTR2-treated groups might be taking place to overcome the protein deficits caused by SSTR2 antibody and supported the new therapeutic intervention with SSTR2 antagonist for neuronal degeneration following nerve injury.